Cost-Effectiveness Analysis of Adjuvant Therapy for BRAF-Mutant Resected Stage III Melanoma in Medicare Patients
Year: 2021
Type: article
Source: Annals of Surgical Oncology
Authors: Saam A. Mojtahed, Nicole R. Boyer, Saieesh A. Rao, Thomas F. Gajewski, Jennifer Tseng, Kiran K. Turaga
Institution: University of Chicago
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
Funder: Pritzker School of Medicine
OpenAlex ID: W3170014716